Company: UTZ
Filing Date: 2025-03-13
Form Type: DEF 14A
Source: 0000950170-25-038342
Chunk: 8

Company: Utz Brands, Inc.
Filing Date: 2025-03-13
Form: DEF 14A
Chunk 8
---
 Jr. and their current terms expire at the 2025 Annual Meeting of Stockholders; and ▪ Our Class III directors are Timothy Brown, Christina Choi, Roger Deromedi, and Dylan Lissette, and their current terms expire at the 2026 Annual Meeting of Stockholders. Action will be taken at the Annual Meeting for the election of four Class II directors, Antonio Fernandez, Craig Steeneck, Pamela Stewart, and William Werzyn, Jr. Each of the nominees is currently a director of the Company. Each director elected at the Annual Meeting will serve until the 2028 annual meeting of stockholders or until his/her successor is elected and qualified. The Board has no reason to believe that any of the nominees for director will not be available to stand for election as director. However, if some unexpected occurrence should require the substitution by the Board of some other person or persons for any one or more of the nominees, then the proxies may be voted in accordance with the discretion of the named proxies “FOR” such substitute nominees. Under the Investor Rights Agreement, subject to certain step-down provisions, the Company, the Founder Holders and the Continuing Members will take all necessary action (to the extent such actions are not prohibited by applicable law and within such party’s control, and in the case of any action that requires a vote or other action on the part of the Board to the extent such action is consistent with fiduciary duties that the Company’s directors may have in such capacity) (such actions, the “Necessary Action”) to include in the slate of nominees recommended by the Board for election as directors at each annual or special meeting of stockholders at which directors are to be elected a certain number of director nominees recommended by each of the Continuing Members (the “Continuing Member Nominees”) and following the dissolution of the Sponsor, the Sponsor Representative (the “Sponsor Nominees”) to be members of our Board of Directors. As of the date of this Proxy Statement, the Continuing Members are entitled to designate five Continuing Member Nominees and the Sponsor Representative is entitled to designate four Sponsor Nominees under the Investor Rights Agreement. Each of Mr. Fernandez and Mr. Steeneck is Sponsor Nominees, and Mr. Werzyn is a Continuing Member Nominee. For more information on the Investor Rights Agreement and other stockholders’ agreements, see “Related Party Transactions— Investor Rights Agreement” on page 65. Vote Require d With regard to this Proposal No. 1 (Election of